NR1I2 and metabolic dysfunction-associated steatotic liver disease: PXR ablation alleviates steatohepatitis in high-fat diet-induced obesity mice and genetic obesity model ob/ob mice, suggesting the therapeutic potential of PXR antagonists in NAFLD [223].